Insulin-like growth factor 2 mRNA-binding protein 2 (IGF2BP2) is involved in the stimulation of insulin action. Polymorphisms in the IGF2BP2 gene have been analyzed in numerous studies to assess the type 2 diabetes (T2D) risk attributed to these variants, but results are conflicting. To better understand the effect of rs4402960 polymorphism on T2D risk, we performed a comprehensive meta-analysis that included 35 published studies involving 70,261 cases and 100,567 controls. The relatively infrequent T variant was significantly associated with T2D with a per-allele odds ratio (OR) of 1.14 (95% confidence interval (CI): 1.12–1.16; p<10−5). Significant results were also observed for heterozygous (OR=1.17, 95% CI: 1.14–1.20; p<10−5) and homozygous (OR=1.23, 95% CI: 1.16–1.30; p<10−5) compared with wild type. In the subgroup analysis by ethnicity, significantly increased risks were found in East Asian, Caucasian and Indian populations. However, no significant associations were detected among other ethnicities. In the stratified analysis according to sample size, diagnostic criterion, mean body mass index, and age of cases significantly increased risks for the polymorphism were found in all genetic models. In conclusion, this meta-analysis suggests that rs4402960 polymorphism in IGF2BP2 is associated with elevated T2D risk, but these associations vary in different ethnic populations.
Get full access to this article
View all access options for this article.
References
1.
AltshulerD., HirschhornJ.N., KlannemarkM.et al.2000. The common PPARgamma Pro12Ala polymorphism is associated with decreased risk of type 2 diabetes. Nat Genet, 26:76–80.
2.
BaierL.J., HansonR.L.2004. Genetic studies of the etiology of type 2 diabetes in Pima Indians: hunting for pieces to a complicated puzzle. Diabetes, 53:1181–1186.
3.
BronsteinM., PisantéA., YakirB., DarvasiA.2008. Type 2 diabetes susceptibility loci in the Ashkenazi Jewish population. Hum Genet, 124:101–104.
4.
CauchiS., MeyreD., DurandE.2008a. Post genome-wide association studies of novel genes associated with type 2 diabetes show gene-gene interaction and high predictive value. PLoS One, 3:e2031.
5.
CauchiS., NeadK.T., ChoquetH.et al.2008b. The genetic susceptibility to type 2 diabetes may be modulated by obesity status: implications for association studies. BMC Med Genet, 9:45.
6.
ChauhanG., SpurgeonC.J.et al.2010. Impact of common variants of PPARG, KCNJ11, TCF7L2, SLC30A8, HHEX, CDKN2A, IGF2BP2 and CDKAL1 on the risk of type 2 diabetes in 5164 Indians. Diabetes, 59:2068–2074.
7.
ChristiansenJ., KolteA.M., HansenT.O., NielsenF.C.2009. Igf2 mrna-binding protein 2: biological function and putative role in type 2 diabetes. J Mol Endocrinol, 43:187–195.
8.
CuginoD., GianfagnaF., SantimoneI., de GaetanoG., DonatiM.B., IacovielloL., Di CastelnuovoA.2011. Type 2 diabetes and polymorphisms on chromosome 9p21: a meta-analysis. Nutr Metab Cardiovasc Dis[Epub ahead of print]10.1016/j.numecd.2010.11.010
9.
DuesingK., FatemifarG., CharpentierG.et al.2008. Evaluation of the association of IGF2BP2 variants with type 2 diabetes in French Caucasians. Diabetes, 57:1992–1996.
10.
EggerM., Davey SmithG., SchneiderM., MinderC.1997. Bias in meta-analysis detected by a simple, graphical test. BMJ, 315:629–634.
11.
FraylingT.M., TimpsonN.J., WeedonM.N.et al.2007. A common variant in the FTO gene is associated with body mass index and predisposes to childhood and adult obesity. Science, 316:889–894.
12.
GloynA.L., WeedonM.N., OwenK.R.et al.2003. Large-scale association studies of variants in genes encoding the pancreatic beta-cell KATP channel subunits Kir6.2 (KCNJ11) and SUR1 (ABCC8) confirm that the KCNJ11 E23K variant is associated with type 2 diabetes. Diabetes, 52:568–572.
13.
GrarupN., RoseC.S., AnderssonE.A.et al.2007. Studies of association of variants near the HHEX, CDKN2A/B and IGF2BP2 genes with type 2 diabetes and impaired insulin release in 10,705 Danish subjects: validation and extension of genome-wide association studies. Diabetes, 56:3105–3111.
14.
HanX., LuoY., RenQ.et al.2010. Implication of genetic variants near SLC30A8, HHEX, CDKAL1, CDKN2A/B, IGF2BP2, FTO, TCF2, KCNQ1, and WFS1 in type 2 diabetes in a Chinese population. BMC Med Genet, 11:81.
15.
HerderC., RathmannW., StrassburgerK.et al.2008. Variants of the PPARG, IGF2BP2, CDKAL1, HHEX, and TCF7L2 genes confer risk of type 2 diabetes independently of BMI in the German KORA studies. Horm Metab Res, 40:722–726.
16.
HorikawaY., MiyakeK., YasudaK., EnyaM., HirotaY.et al.2008. Replication of genome-wide association studies of type 2 diabetes susceptibility in Japan. J Clin Endocrinol Metab, 93:3136–3141.
17.
HorikoshiM., HaraK., ItoC., ShojimaN., NagaiR., UekiK., FroguelP., KadowakiT.2007. Variations in the HHEX gene are associated with increased risk of type 2 diabetes in the Japanese population. Diabetologia, 50:2461–2466.
18.
HuangQ., YinJ.Y., DaiX.P.et al.2010. IGF2BP2 variations influence repaglinide response and risk of type 2 diabetes in Chinese population. Acta Pharmacol Sin, 31:709–717.
19.
HuC., ZhangR., WangC.et al.2009. PPARG, KCNJ11, CDKAL1, CDKN2A-CDKN2B, IDE-KIF11-HHEX, IGF2BP2 and SLC30A8 are associated with type 2 diabetes in a Chinese population. PLoS One, 4:e7643.
20.
LeeY.H., KangE.S., KimS.H., HanS.J., KimC.H., KimH.J., AhnC.W., ChaB.S., NamM., NamC.M., LeeH.C.2008. Association between polymorphisms in SLC30A8, HHEX, CDKN2A/B, IGF2BP2, FTO, WFS1, CDKAL1, KCNQ1 and type 2 diabetes in the Korean population. J Hum Genet, 53:991–998.
21.
LewisJ.P., PalmerN.D., HicksP.J., SaleM.M., LangefeldC.D., FreedmanB.I., DiversJ., BowdenD.W.2008. Association analysis in African Americans of European-derived type 2 diabetes single nucleotide polymorphisms from whole-genome association studies. Diabetes, 57:2220–2225.
22.
LinY., LiP., CaiL.et al.2010. Association study of genetic variants in eight genes/loci with type 2 diabetes in a Han Chinese population. BMC Med Genet, 11:97.
23.
LiuY., YuL., ZhangD.et al.2008. Positive association between variations in CDKAL1 and type 2 diabetes in Han Chinese individuals. Diabetologia, 51:2134–2137.
24.
LyssenkoV., JonssonA., AlmgrenP., PulizziN.et al.2008. Clinical risk factors, DNA variants, and the development of type 2 diabetes. N Engl J Med, 359:2220–2232.
25.
NgM.C., ParkK.S., OhB., TamC.H., ChoY.M.et al.2008. Implication of genetic variants near TCF7L2, SLC30A8, HHEX, CDKAL1, CDKN2A/B, IGF2BP2, and FTO in type 2 diabetes and obesity in 6,719 Asians. Diabetes, 57:2226–2233.
26.
NielsenJ., ChristiansenJ., Lykke-AndersenJ., JohnsenA.H., WewerU.M., NielsenF.C.1999. A family of insulin-like growth factor II mRNA-binding proteins represses translation in late development. Mol Cell Biol, 19:1262–1270.
27.
OmoriS., TanakaY., TakahashiA.et al.2008. Association of CDKAL1, IGF2BP2, CDKN2A/B, HHEX, SLC30A8, and KCNJ11 with susceptibility to type 2 diabetes in a Japanese population. Diabetes, 57:791–795.
28.
O'RahillyS., BarrosoI., WarehamN.J.2005. Genetic factors in type 2 diabetes: the end of the beginning?Science, 307:370–373.
29.
ReesS.D., HydrieM.Z., SheraA.S.et al.2011. Replication of 13 genome-wide association (GWA)-validated risk variants for type 2 diabetes in Pakistani populations. Diabetologia, 54:1368–1374.
30.
RodriguezS., EiriksdottirG., GauntT.R., HarrisT.B., LaunerL.J., GudnasonV., DayI.N.2010. IGF2BP1, IGF2BP2 and IGF2BP3 genotype, haplotype and genetic model studies in metabolic syndrome traits and diabetes. Growth Horm IGF Res, 20:310–318.
31.
RongR., HansonR.L., OrtizD., WiedrichC., KobesS., KnowlerW.C., BogardusC., BaierL.J.2009. Association analysis of variation in/near FTO, CDKAL1, SLC30A8, HHEX, EXT2, IGF2BP2, LOC387761, and CDKN2B with type 2 diabetes and related quantitative traits in Pima Indians. Diabetes, 58:478–488.
32.
SandhuM.S., WeedonM.N., FawcettK.A.et al.2007. Common variants in WFS1 confer risk of type 2 diabetes. Nat Genet, 39:951–953.
33.
SangheraD.K., OrtegaL., HanS., SinghJ., RalhanS.K., WanderG.S., MehraN.K.et al.2008. Impact of nine common type 2 diabetes risk polymorphisms in Asian Indian Sikhs: PPARG2 (Pro12Ala), IGF2BP2, TCF7L2 and FTO variants confer a significant risk. BMC Med Genet, 9:59.
34.
SaxenaR., VoightB.F., LyssenkoV.et al.2007. Genome-wide association analysis identifies loci for type 2 diabetes and triglyceride levels. Science, 316:1331–1336.
35.
ScottL.J., MohlkeK.L., BonnycastleL.L.et al.2007. A genome-wide association study of type 2 diabetes in Finns detects multiple susceptibility variants. Science, 316:1341–1345.
36.
ShuX.O., LongJ., CaiQ.et al.2010. Identification of new genetic risk variants for type 2 diabetes. PLoS Genet, 6:e1001127.
37.
SladekR., RocheleauG., RungJ.et al.2007. A genome-wide association study identifies novel risk loci for type 2 diabetes. Nature, 445:881–885.
38.
TabaraY., OsawaH., KawamotoR., OnumaH., ShimizuI., MikiT., KoharaK., MakinoH.2009. Replication study of candidate genes associated with type 2 diabetes based on genome-wide screening. Diabetes, 58:493–498.
39.
TakeuchiF., OchiaiY., SerizawaM.et al.2008. Search for type 2 diabetes susceptibility genes on chromosomes 1q, 3q and 12q. J Hum Genet, 53:314–324.
40.
TakeuchiF., SerizawaM., YamamotoK., FujisawaT.et al.2009. Confirmation of multiple risk Loci and genetic impacts by a genome-wide association study of type 2 diabetes in the Japanese population. Diabetes, 58:1690–1699.
41.
TanJ.T., NgD.P., NurbayaS.et al.2010. Polymorphisms identified through genome-wide association studies and their associations with type 2 diabetes in Chinese, Malays, and Asian-Indians in Singapore. J Clin Endocrinol Metab, 95:390–397.
42.
UnokiH., TakahashiA., KawaguchiT.et al.2008. SNPs in KCNQ1 are associated with susceptibility to type 2 diabetes in East Asian and European populations. Nat Genet, 40:1098–1102.
43.
van HoekM., DehghanA., WittemanJ.C.et al.2008. Predicting type 2 diabetes based on polymorphisms from genome-wide association studies: a population-based study. Diabetes, 57:3122–3128.
44.
WenJ., RönnT., OlssonA.et al.2010. Investigation of type 2 diabetes risk alleles support CDKN2A/B, CDKAL1, and TCF7L2 as susceptibility genes in a Han Chinese cohort. PLoS One, 5:e9153.
45.
WilsonP.W., MeigsJ.B., SullivanL., FoxC.S., NathanD.M., D'AgostinoR.B.Sr.2007. Prediction of incident diabetes mellitus in middle-aged adults: the Framingham Offspring Study. Arch Intern Med, 167:1068–1074.
46.
WuY., LiH., LoosR.J., YuZ., YeX., ChenL., PanA., HuF.B., LinX.2008. Common variants in CDKAL1, CDKN2A/B, IGF2BP2, SLC30A8, and HHEX/IDE genes are associated with type 2 diabetes and impaired fasting glucose in a Chinese Han population. Diabetes, 57:2834–2842.
47.
XuM., BiY., XuY.et al.2010. Combined effects of 19 common variations on type 2 diabetes in Chinese: results from two community-based studies. PLoS One, 5:e14022.
48.
ZegginiE., WeedonM.N., LindgrenC.M., FraylingT.M., ElliottK.S., LangoH., TimpsonN.J.et al.2007. Replication of genome-wide association signals in UK samples reveals risk loci for type 2 diabetes. Science, 316:1336–1341.
Supplementary Material
Please find the following supplemental material available below.
For Open Access articles published under a Creative Commons License, all supplemental material carries the same license as the article it is associated with.
For non-Open Access articles published, all supplemental material carries a non-exclusive license, and permission requests for re-use of supplemental material or any part of supplemental material shall be sent directly to the copyright owner as specified in the copyright notice associated with the article.
